ANEBULO PHARMACEUTICALS, INC. (ANEB) Operating income 2021–2025
ANEBULO PHARMACEUTICALS, INC. (ANEB) annual operating income history from SEC filings — each fiscal year as reported.
-$9.2MFY2025 · since FY2021: -$3.6M → -$9.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.2M | -11.0% |
| FY2024 | -$8.3M | +29.5% |
| FY2023 | -$11.8M | -72.5% |
| FY2022 | -$6.8M | -89.0% |
| FY2021 | -$3.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice